Kooth PLC (AIM:KOO), a front-runner in the personalised digital mental health sector, could offer a significant value proposition for investors, according to a recent note by UK brokerage firm Liberum.
The company's shares, currently priced at 346p, are undervalued based on Liberum's price target of 457p.
But the growth potential doesn't stop there. Liberum points to the potential for more US contracts and licensing opportunities, which could add a further 400p over time, effectively more than doubling the company's share price.
The timing couldn't be better for Kooth, as it enters the fray in a world grappling with a mental health crisis. It's one of the few companies with a proven solution to address this, and it's already a market leader in the UK.
Recently, the company managed to secure transformational contracts in the US, worth $180 million and indicating its scalability and potential for international expansion. The California deal is a prime example of this, which could potentially triple Kooth's revenue.
As the company moves forward, key value drivers will include technology updates for the California contract, scaling up in Pennsylvania and California, and renewing the Pennsylvania contract. However, it should be noted that there is a high execution risk over the next twelve months.
Liberum emphasises what the market might be overlooking. The breadth and scalability of Kooth's offerings are difficult to replicate, making it a unique player in the sector. Licensing will also enable Kooth to scale rapidly and with less risk.
To summarise, Liberum's analysis suggests Kooth's existing business operations and contracts already justify a higher share price of 457p. Additional opportunities in US expansion and licensing could add up to 400p more, indicating a highly attractive investment potential.